Intervertebral disc degeneration and chronic back pain are not exclusive to humans. Companion animals, particularly dogs, can also be affected by degenerative spinal conditions that compromise mobility, quality of life, and overall well-being. Advancing regenerative therapies for veterinary medicine therefore represents an important opportunity to improve animal health while contributing to broader innovation in regenerative medicine.
Fetalix has released a new video highlighting its vision for the veterinary sector and presenting the potential of its fetal-inspired regenerative biomaterial technology to support future applications in companion animal health.
The video raises awareness of the impact of spinal degeneration in animals and explores how regenerative biomaterial-based approaches could contribute to tissue repair and improved clinical outcomes. It also reflects Fetalix's One Health approach, recognizing that advances in regenerative medicine can generate benefits across both veterinary and human healthcare through shared scientific and technological development.
By sharing this vision, Fetalix aims to increase awareness of the unmet needs in veterinary regenerative medicine while reinforcing its commitment to developing innovative therapies capable of improving the quality of life of both animals and people.
January 30, 2025
